Lack of nephrotoxicity following 15-day therapy with high doses of colistin in rats

Medical Science Monitor

Volumn 14, Issue 4, 2008, Pages

  Hakim, Ahmed ^a   Kallel, Hatem ^b   Sahnoun, Zouheir ^a   Badraoui, Riadh ^a   Jammoussi, Kamel ^b   Bouaziz, Mounir ^b   Zeghal, Khaled Mounir ^a   Rebaii, Tarak ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Colistin; Rats; Renal failure

Indexed keywords

COLISTIN; CREATININE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; HISTOLOGY; KIDNEY STRUCTURE; MALE; NEPHROTOXICITY; NONHUMAN; RAT; TOXICITY TESTING; UREA NITROGEN BLOOD LEVEL; WISTAR RAT;

ANIMALS; COLISTIN; KIDNEY; MALE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 42049101210     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Falagas ME, Kasiakou SK: Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care, 2006; 10: R27
2. Levin AS, Barone AA, Penco J et al: Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin Infect Dis, 1999; 28: 1008-11
3. Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V: Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis, 2007; 11: 402-6
4. Falagas ME, Rafailidis PI, Kasiakou SK et al: Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin Microbiol Infect, 2006; 12: 1227-30
5. Falagas ME, Kasiakou SK, Kofteridis DP et al: Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis, 2006; 25: 596-99
6. Falagas ME, Fragoulis KN, Kasiakou SK et al: Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents, 2005; 26: 504-7
7. Michalopoulos AS, Tsiodras S, Rellos K et al: Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect, 2005; 11: 115-21
8. Falagas ME, Rizos M, Bliziotis IA et al: Toxicity after prolonged (more than four weeks) administration of intravenous colistin. BMC Infect Dis, 2005; 5: 1
9. Conway SP, Pond MN, Watson A et al: Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax, 1997; 52: 987-93
10. Markou N, Apostolakos H, Koumoudiou C et al: Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care, 2003; 7: R78-83
11. Linden PK, Kusne S, Coley K et al: Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis, 2003; 37: e154-60
12. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ et al: Treatment of multidrug-resistant Acinetobacter baumanii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis, 2003; 36: 1111-18
13. Kallel H, Hergafi L, Bahloul M et al: Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med, 2007; 33: 1162-67
14. Kallel H, Bahloul M, Hergafi L et al: Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int J Antimicrob Agents, 2006; 28: 366-69
15. Li J, Nation RL, Turnidge JD: Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization. Antimicrob Agents Chemother, 2006; 50: 4231
16. Li J, Nation RL, Turnidge JD et al: Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis, 2006; 6: 589-601
17. Daram SR, Gogia S, Bastani B: Colistin-associated acute renal failure: revisited. South Med J, 2005; 98: 257-58
18. Kallel H, Hamida CB, Ksibi H et al: Suspected acute interstitial nephritis induced by colistin. J Nephrol, 2005;18: 323-26
19. Berg JR, Spilker CM, Lewis SA: Modulation of polymyxin B the effects on mammalian urinary bladder. Am J Physiol, 1998; 275: 204-15
20. Lewis JR, Lewis SA: Colistin interactions with the mammalian urothelium. Am J Physiol Cell Physiol, 2004; 286: 913-22